Novartis Scales Down After Vasella

Novartis distancing itself from the era of former Chairman Vasella, whose exit package blemished the Swiss pharmaceutical company's image when he stepped down a year ago.



from WSJ.com: US Business http://ift.tt/Mpu2tU

via IFTTT